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Modeling the complete actin.myosin ATPase cycle has always been limited by the lack of 
experimental data concerning key steps of the cycle because these steps can only be defined at 
very low ionic strength.  Here using the human beta-cardiac myosin-S1 we combine published 
data from transient and steady-state kinetics to model a minimal eight state ATPase cycle.   The 
model illustrates the occupancy of each intermediate around the cycle and how the occupancy is 
altered by changes in actin concentration for [actin] = 1-20 D?D?.   The cycle can be used to 
predict the maximum velocity of contraction (motility assay or sarcomeric shortening) at 
different actin concentrations (which are consistent with experimental velocity data) and predict 
the effect of a 5 pN load on a single motor.   The same exercise was repeated for the human 
alpha-cardiac myosin S1 and rabbit fast skeletal muscle S1. The data illustrates how the motor 
domain properties can alter the ATPase cycle and hence the occupancy of the key states in the 
cycle.  These in turn alter the predicted mechanical response of the myosin independent of other 
factors present in a sarcomere such as filament stiffness and regulatory proteins.   We also 
explore the potential of this modeling approach for the study of mutations in human beta cardiac 
myosin using the hypertrophic myopathy mutation R453C.  Our modeling, using the transient 
kinetic data of Bloemink et al. (2014, J. Biological Chemistry 289:5158-516) predicts the 
mechanical properties of the motor that are compatible with the single molecule study of 
Sommese et al. (2013, PNAS 110:12607-12612).  The modeling approach may therefore be of 











The actomyosin ATPase cycle has been studied since myosin was first isolated and 
recognised as an ATPase (1-3).  The biochemical kinetics of the cycle have been defined using 
steady-state and transient kinetics methods for different myosin isoforms (both muscle and non-
muscle) and under a range of different experimental conditions (4, 5).    The major events around 
the cycle remain the same for all myosins studied to date (see Fig. 1) but with alterations in the 
overall cycle speed and the fraction of the cycle time spent in the different intermediates around 
the cycle, e.g. the duty ratio (6-8).  These alterations in the cycle tune the myosin to a specific 
function which for the sarcomeric myosin IIs include shortening velocity, steady-state force and 
efficiency defined as force per ATP etc. (9).   While these results have led to a good 
understanding of the molecular and structural changes in the cycle understanding how these 
operate in the cell is often more difficult.  Two missing elements in any model of the cycle in 
solution are how load on the motor alters the cycle and the effective actin concentration the 
myosin is exposed to.  Any model of the cross bridge cycle has to build in these two elements to 
create a description of the working system.  We present here a cross bridge model which 
examines these two elements in relation to the differences between the major muscle myosin II 
LVRIRUPVIDVWVNHOHWDOP\RVLQUDEELWP\RVLQDDQGWKHWZRKXPDQFDUGLDFLVRIRUPVĮDQGȕ  
7KHȕ-cardiac isoform is identical to the slow muscle isoform.  
We have recently completed a kinetic analysis of the slow skeletal/ ȕ-cardiac muscle 
isoform of both bovine (10) and human myosin II (11). The step size and load dependence of the 
$'3UHOHDVHVWHSKDVUHFHQWO\EHHQGHILQHGIRUWKHKXPDQDQGSRUFLQHȕ-cardiac isoform (12, 
13).  It is therefore a good time to attempt to model the complete ATPase cycle for this well-
defined slow muscle isoform (MyHC-7) and compare it with the closely related faster isoforms, 
i.e. WKHLVRIRUPIRXQGLQWKHKXPDQDWULXPĮ-cardiac, (MyHC6) which we have also studied 
(11) and the well characterised fast skeletal 2a isoform from rabbit (MyHC2). 
The work presented here is part of a broader effort to develop a suite of programmes 
(MUSICO) that can model different aspects of muscle contraction from the molecular interaction 
of individual proteins through to the contracting muscle fiber.  Here the ATPase cycle is modeled 
as a first step in this process. For a quantitative understanding of the ATPase in solution the data 
analysis should be performed on actomyosin-ATPase cycle model with a sufficient number of 
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states as, for example the minimum cycle set out in Fig. 1.   In this ATPase cycle there are 8 
intermediates defined by 9 equilibrium and 18 rate constants.  Since the rate and equilibrium 
constants are not independent only 18 constants are required for a complete description of the 
cycle.  From the published transient kinetic studies it is possible to define many of the constants.  
$VVHWRXWLQWKHPHWKRGVIRUWKHȕ-myosin and listed in Table S1 three forward rate constants 
(D?஽כ, D?்כ, D?ு) and two equilibrium constants (D?்  and D?஽D?஽כ) can be measured with precision of 
at least 20%.   Three steps are defined as diffusion limited with a minimum value of 107 M-1s-1 
(D?஺, D?் and D?ି஽), and two other events are estimated to be too fast to measure and therefore have 
little  influence on the modeling (D?்ככ, D?ି஺), which together allows one equilibrium  constant and 
three rate constants to be defined by detailed balance (D?் , D?஽, D?ି஽כ, D?ି்).  The remaining 5 
constants (D?஺,  D?ு, D?஺ு, and the rate constants D?ି௉௜ and D?ି்) can be defined by fitting the model 
to the actin dependence of the steady state ATPase data and this analysis is presented here.   
The experimental data used show clear differences in the three myosin isoforms.  Our 
modeling illustrates how the properties of the isolated motor define the overall properties of the 
cycle, and how the myosin isoform can define the velocity at which the myosins can move actin, 
the load dependence of the cycle and the force generating capacity.   In broad-brush terms the 
predictions based on simple solution kinetic measurements are compatible with the known 
properties of muscle fibers expressing these isoforms.   Exact matching of the model to the data 
is not to be expected since additional parameters come in to play in the contracting muscle fiber 
such as the relative geometry of the actin myosin filaments, the stiffness of the structural 
elements and the ancillary proteins such as troponin, titin and myosin binding protein C. Thus, 
our aim here is not to match the fiber properties precisely but to explore the extent to which the 
myosin isoform properties themselves define the contraction properties of the sarcomere. 
METHODS 
The rate kinetic process for ATP cycle shown in Fig. 1 can be described as a system of 
linear equations that define the rate of change in state concentration as a function of the 
instantaneous fluxes between the states: D?&ȀD?D? ൌ.&         (1) 
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Where & is a vector of the eight state concentrations form ATP-ase cycle (Fig. 1), i.e. & ൌ൛ሾ0'3Lሿǡ ൣ$-0'3L൧ǡ ሾ$0'ሿǡ ൣ$0-'൧ǡ ሾ$0ሿǡ ሾ$07ሿǡ ൣ$-07൧ǡ ሾ07ሿൟ், and . is a matrix defining the state transition rates from and 
into each state.  The general solution of this system of equation provides the transient response of each state from an initial state to the 
steady state solution. However, the matrix . is singular because the sum of all the rows is a row of zeroes, and therefore the 
determinant of ȁ.ȁ ൌ  ?. Thus, for unique solution of Eq. 1, it is necessary to replace in . one row by the constraint equation 
coefficients derived from preservation of myosin species, i.e. the sum of concentrations of all states containing myosin should be equal 
to total myosin concentration ሾ0WRWሿat any instant D? (14-16):   









In the steady state, the increment in state concentration is equal to zero, i.e. D?&ȀD?D? ൌ  ?, and after inclusion of the conservation 
of myosin species constraint the steady state concentrations can be calculated from: 
&ൌ.ିଵ%         (2) 
where the vector % ሺ ?ǡ  ?ǡ  ?ǡ  ?ǡ  ?ǡ  ?ǡ  ?ǡ ሾ0WRWሿሻࢀ includes the total concentration of myosin that is typically input parameter.  The 
system of equations (Eq.2) is nonlinear because the state transition rates  D?஺, D?ି்ככ and D?ି஺ு depend on the concentration of available  
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actin sites, ሾሿ, that is a priori  unknown, but for a known number of myosins bound to actin (in 
6 actin-myosin states), the concentration of available actin sites can be calculated from: ሾሿ ൌ ሾƚŽƚሿ െ ሺሾͲDWŝሿ ൅ ሾDሿ ൅  ሾDǦሿ ൅ ሾDሿ ൅ ሾDdሿ ൅ ሾͲDdሿሻ 
Thus, the concentration [A] can only be obtained iteratively. The first order differential Eq. 2 is 
solved numerically by a forward iterative procedure. Setting the initial value for [A] = [Atot], in 
each time step, after updating [A] in each iteration, the solution of Eq. 2 is typically obtained in 
less than twenty iterations.   
Parameter estimation methods 
There are many different methods for estimating parameters by fitting experimental data 
for example widely used global fitting KinTek Explorer (17-19). This global fitting software is 
successfully used for estimating rate and equilibrium constants a ATPase by globally fitting 
transient kinetic data of the Dbp5 ATPase cycle (20). However the global fitting methods may 
not be appropriate for fitting the experiments with simulations requiring a long time for each 
iteration and very large number of iterations thus we have developed several methods for the 
estimation of the model parameters for fitting kinetics data (21). The effective method for 
parameter estimation is the  Damped Least Square (DLS) method, i.e. Levenberg±Marquardt 
inversion, because of two important features: a quantitative evaluation of the uniqueness of the 
estimated parameters and the degree of parameter interdependence via a parameter resolution 
matrix (21, 22). The DLS method is based on the iterative minimization of the mean-square error 
of the model predictions with respect to experimental observations. In this study, we estimate the 
rate transition constants of the ATPase cycle shown in Fig. 1, by minimizing the variance 
between the predicted steady state ATP-ase rates over a range of actin concentrations. The 
observations covered a range of independent variables, wide enough, to uniquely resolve the set 
of model parameters for each myosin isoform. These observations ࢊREVሺሾD?ሿሻ are represented by a 
set on N values of the ATP-ase rate sampled at discrete actin concentrations. The deviation of the 
model predictions from the experimental observations is represented by the mean-square-error 
that is an integral measXUHRIWKH³JRRGQHVV´RIWKHPRGHOSUHGLFWLRQILWWRWKHREVHUYDWLRQV
Minimization of the mean square function provides the set of (free) parameters that best fit the 
experimental data using the iterative procedure described in (21).  
The sensitivity of the model responses to each of the estimated parameters is examined 
by the resolution matrix 5 (an D? ൈ D? matrix) at convergence: when 5׽,, the estimated model 
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parameters are uniquely determined, whereas when the matrix 5 has appreciable non-zero off-
diagonal elements, variations of a particular parameter can be compensated by adjustments of 
other parameters that fit the experimental data equally well suggesting that the parameters are 
interdependent and cannot be uniquely resolved. Furthermore, if all the elements in a row of the 
resolution matrix are small then the corresponding parameter cannot be estimated for the given 
data set because the error is affected very little, even by large changes in this parameter. 
In DLS, the iterative process is stopped when the error and the norm of the increment of 
the estimated parameters are less than the prescribed respective tolerances. Also the maximal 
number of iterations is usually limited (here, the limit was 100) and the convergence is typically 
reached in 30-50 steps). 
Estimation of rate constants 
Choosing a set of rate constant for this study depends upon having a good estimate of the 
steady state ATPase data and a complete set of the rate constants for the cycle depicted in Fig 1.   
The problem is the conditions used for such measurement rarely match.   The key ATP-ase 
measurements are obtained in solution by estimating the ATPase turnover rate, D? as a function of 
varying actin concentration.  These define D?௠௔௫  and  D?௠ via the classical Michaelis-Menten 
equation,  D? ൌ  D?௠௔௫ሾD?ሿȀሺሾD?ሿ  ൅ D?௠ሻ. Actin activated ATPase assays require very low ionic 
strengths for the value of D?௠  to be in an accessible range of actin concentrations.   ATPase 
assays cannot normally be performed at actin concentrations  > 100 mM (5 mg/ml) because of 
the high viscosity of the solution and the excessive amounts of actin required.  Thus ATPase 
assays are restricted to ionic strengths < 0.03M.   In contrast, most assays of the cycle transient 
kinetics have used a much higher ionic strength to be close to those under physiological 
condition.    Here we use complete fast kinetic data sets collected at 25 mM KCl and 100 mM 
KCl,  for both the rabbit fast-VNHOHWDOPXVFOH6SUHGRPLQDQWO\WKHDLVRIRUPDQGKXPDQȕ-
cardiac/slow skeletal  isoform.  ATPase data have been published for both proteins at 25 mM 
KCl  (rabbit (23)EHWDȕ-cardiac (24)7KHWUDQVLHQWGDWDIRUUDEELWIDVWDQGKXPDQȕ-cardiac 
S1 at 100 mM KCl  are from (11). The data for the beta cardiac S1 at 25 mM KCl was published 
in (25) and the rabbit data was collected specifically for this work using the identical approaches.   
The values used are listed in Table 1.  The assignment of each rate and equilibrium constant is 
VHWRXWEHORZIRUȕ-cardiac at 25 mM KCl and the same approach was taken to assign the values 
for other proteins (see Supporting Material for detailed information, Table S1).    
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For each step i in the cycle of Fig. 1 we can define D?௜ ൌ D?௜ȀD?ି௜ where D?௜   is the 
equilibrium constant of the ith step and D?௜ and D?ି௜ are the forward and reverse rate constants 
(defined in a clockwise direction in Fig 1) respectively. Note the nomenclature for rate and 
equilibrium constants uses the subscript ( A, D, Pi, T)  to indicate the species binding or released 
from myosin in each 2nd order step.  A star (*) indicates that it is an isomerisation event linked 
with the 2nd order binding or dissociation event.  The only exception is D?ு and D?஺ு  which are 
the ATP hydrolysis steps with or without actin attached. Defining any two of the three 
parameters experimentally is sufficient; the third can be calculated from the first two. ATP 
binding occurs in two steps of which a rapid equilibrium step D?்
 
which is defined experimentally 
in transient studies.  The forward rate constant D?் is assumed to be diffusion limited (a nominal 
value of 107 M-1s-1 is assigned to all diffusion limited steps)  and the reverse rate constant D?ି்  
obtained by calculation D?ି் = 107/ 3.06 x 103 = 3270 s-1 (illustrated for the ȕ-cardiac myosin, see 
Table 1 for estimated value from the data fit). On ATP binding the actomyosin complex 
undergoes a rapid isomerization controlled by D?்כ which is measured as the limiting rate of ATP 
binding as 1540 s-1.  This is a largely irreversible step so the reverse rate constant, D?ି்כ,  is set at 
a nominal 10 s-1 giving D?் כ as 154. Actin then rapidly detaches with a rate constant, D?்ככ, which 
is at least as fast as D?்כ and is set at a nominal 1000 s-1 and the reverse rate at 1 PM-1s-1,
 
to give 
an affinity of actin for MT of ~ 1 mM  about 10 fold weaker than that expected for MDPi.  The 
rate constant for the ATP hydrolysis step is set either by quenched flow studies or as the 
maximum rate of the tryptophan fluorescence change on ATP binding to S1 having typical rate D?ு ൅ D?ିு  ? 15 s-1.  The equilibrium constant is not well defined but is thought to be between 1 
and 10, and we have (initially) assigned D?ு = 14 s-1 and D?ିு= 1.4 s-1, see Table 1 for estimated 
value from the data fit. Actin rebinding occurs from the M.ADP.Pi states and actin induces the 
release of Pi and the transition to the force developing strongly attached AMD sate.   Neither of 
these steps can be easily distinguished from preceding or following steps in a direct assay.  The 
values were therefore defined from the fit to the actin dependence of the steady state ATPase 
data.  
A load dependent isomerization of AMD follows Pi release and the forward rate constant 
LVGLUHFWO\PHDVXUHGIRUȕ6E\GLVSODFLQJ$'3E\DODUge excess of ATP. This defines D?஽כ as 
59 s-1 and the amplitude analysis defines D?஽כ as 0.167 and hence D?ି஽כ  as 354 s-1.   This step is 
thought to define the maximum shortening velocity of muscle fiber contraction.   It cannot be 
measured for rabbit muscle S1 as D?஽כ  is >> 1.    Estimates of the value of this equilibrium 
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constant from Pi binding studies suggest a value of ~50 (26).   The overall affinity of ADP for 
A.M, D?ௗ௜௦௦௡ , was measured by competition with ATP binding  D?ௗ௜௦௦௡ ൌ D?஽D?஽כ ሺ ? ൅ D?஽כ ? ሻ to 
give the value of D?஽ listed.  The ADP binding rate constant is assumed to be fast and diffusion 
limited while the ADP release is set at a nominal 1000 s-1.  All parameters used and calculated 
here are listed in Table 1 for each of the isoforms.  
There is evidence that at high actin concentration, ATP hydrolysis and reversal of the 
recovery stroke can take place while myosin remains bound to actin, since if this were zero the 
ATPase rate would decline at very high actin concentrations (27). To allow for this we have 
included the step with equilibrium constant D?஺ு. We made no assumption about this step but 
allowed a value to be fitted within the limits of overall detailed balance of the two half cycles 
shown in Fig. 1.  
Fitting data procedure 
In order to quantitatively understand the ATP-ase process with the 8-state model shown 
in Fig. 1 it is necessary to know 18 rate or equilibrium constants.  From multiple measurements 
and the analysis shown above it is possible to define 13 rate constants, thus the remaining 5 can 
be obtained by fitting the ATPase data by predictions of steady state ATPase from the solution of 
Eq. 2.   Note when fitting to steady-state ATPase data in which initial rates are measured the 
concentration of ADP and Pi are assumed to be zero such that Pi and ADP release are 
irreversible.  However, we include estimates of the two equilibrium constants D?௉௜  and D?஽כ  to 
allow a detailed balance calculation.  Using known values of the rate constants in the cycle, we 
estimated unknown values of the equilibrium constants,  D?஺,  D?ு, D?஺ு , and the rate constants,  D?ି௉௜ , and,  D?ି், by the DLS algorithm (21).  The rapid convergence of parameters and the 
diagonal terms in the resolution matrix having values > 0.8 indicate well resolved and 
independent parameters.  
 
RESULTS  
Table 1 lists the rate and equilibrium constant for each of the steps in the cycle outlined 
LQ)LJIRUKXPDQȕ-cardiac motor domain (or S1).   Where measured, each of these kinetic 
constants was defined at ~ 25 mM KCl and 20 °C, with a precision of at least 20%, others were 
assumed from known limits, i.e. diffusion limited, rapid equilibrium step or by detailed balance 
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as set out in the Methods section.  The values undefined in the ATPase cycle are the affinity of 
actin for M.ADP.Pi complex (D?஺ in Fig 1) the rate and equilibrium constants of Pi release,D?௉௜ , 
and for human myosins the equilibrium constant of the ATP hydrolysis step.  One other step not 
well defined is the affinity of the MT state for actin (D?்ככ) that is normally assumed to be very 
weak but since very high actin concentrations were modeled  (as might be found in a sarcomere 
this affinity was set to 1 mM ~ 10 fold weaker than the actin affinity for MDPi ( D?஺)).  We then 
also need to include values for the rate and equilibrium constants of the on-actin hydrolysis step 
(D?஺ு).  We used published values for the steady state ATPase D?௠௔௫  and  D?௠ for the same isoform 
(24) and fitted the model to the data (Fig.  2).  The resulting fitted values are listed in bold in 
Table 1, and the convergence of fitted parameters IRUKXPDQȕ-cardiac-S1 is shown in Fig. 2B, 
and for rabbit fast skeletal, human cardiac D-6DQGKXPDQFDUGLDFȕ-R453C-S1 in Fig. S1.  
In Figure 2A the predicted ATPase rates as a function of actin concentration IRUKXPDQȕ-
cardiac-S1 (based on the published D?௠௔௫  and  D?௠ values) are shown as the blue circles and the 
red line is the best fit to the model.  The convergence of the fitted parameters during the 
simulation is illustrated in Fig 2B and the resolution matrix for each fitted parameter is listed in 
Table 2.   These show that the values rapidly converge and are all well-defined with exception of D?ି்,  the rate constant for ATP dissociation from the rigor A.M complex which is fast ~ 3000 s-1 
and its precise value has little influence on the fitting process.  
It is important to notice that the excellent fits do not guarantee that the parameters are 
uniquely defined. Having diagonal terms of order of 0.9 provides large confidence that the 
separation between parameters is very good, but not perfect (having value of 1). Off-diagonal 
terms <0.25 show only weak interdependence typical for fits of real data.  However, the diagonal 
value of  D?ି் is very small implying that that from these data D?ି் cannot be estimated and the 
small values from off-diagonal terms are irrelevant. This also suggests that using different values 
for D?ି் may not affect the other estimated parameters because of small values of diagonal terms 
i.e. extremely weak interdependence.    
Before considering the implication of the results we examined the robustness of the 
values used.  For each of the fixed values (based on measurements or estimates; the non-bold 
values in Table 1) we changed the value by either +20% or -20% and refitted the ATPase data.   
In almost all cases  case the fitted parameters changes by less than 2% only in the case of a 
change in D?஽ or D?஽כ  were larger changes seen,  D?௉௜  and D?஺ changing by up to 7 % ( see Table 
11 
 
S4).  This indicates that the fitting is relatively independent of the fixed parameter values in the 
range ±20%.  The same test was run for the fitted parameter values; i.e. we altered one of the 
fitted parameters (e.g.  D?ு) by ±20% and refitted the data.  As can be seen from the fitted values 
in Table 1 both D?௉௜  and D?ு   have similar values, ~ 3¯ D?௠௔௫ ǡand contribute significantly to the 
overall ATPase  D?௠௔௫ .  Consequently an increase in D?ு requires a decrease in D?௉௜   and visa-versa 
(See Table S5).   A similar change in the actin affinity D?஺ was also required to fit the data.  A 
change in D?ு also requires a similar change in D?஺ு for thermodynamic balance. The quality of 
the fit judged by the error term (see Fig2B) remains very good. The errors reach the major 
minimum after ~ 10 iterations with small damped fluctuations in error afterwards concurrently 
displaying gradual convergence of the fitted values toward best fit solution.  Thus, although the 
values are well defined by the fit, the values show some, typically minor, degree of dependence 
of each other.  
Because these values may not be fully independent of each other we examined the 
influence of the 20% change in D?ு and fitted values of D?௉௜  and D?஺ for the occupancy of the other 
states in the cycle.  Since the overall ATPase rate (or the flux) does not change there is little 
change in any of the strongly attached states in the cycle (<1%).   The effect is just a 
redistribution between [MT], [MDPi]  and [A-MDPi] to maintain the same flux through this part 
of the cycle (see Table S6)  
Figure 2A illustrates, in a pie-chart, the predicted occupancy of each of the states in the 
cross-bridge cycle model (each state color-coded to match Fig 1) for three actin concentrations 
[A] = D?௠, 3D?௠ and 20D?௠ where the corresponding ATPase rates are 50%,  75% and 95% of D?௠௔௫  respectively.  These three conditions were used to demonstrate how the cycle changes with 
increasing actin concentration.  This also indicates how the situation my appear in an unloaded 
motility assay or rapidly contracting muscle fiber where the value and the meaning of actin 
concentration remains undefined because of the geometric constraints of the system.  The pie-
charts give a visual indication of how the occupancy of each of the cycle intermediates changes 
and allows an easy comparison between actin concentrations and different myosin isoforms (see 
below).  Table S2 gives the calculated values for the state occupancy in each case, while Table 4 
summarizes the changes in the sum of detached (red shades in Fig. 1), weakly (yellow shades) 
and strongly bound (blue shade) states.  As expected, an increase in actin concentration results in 
a gradual shift from detached (MT and MDPi) to actin attached states with the detached MDPi 
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falling from 0.45 to 0.042 as the actin concentration increases from  D?௠ to 20 D?௠.  The weakly 
attached A-MDPi state predominates (pale yellow, 0.36) at saturating actin concentrations and 
the sum of MT (dark red) and A-MT (dark yellow) giving a further 0.46.  The only other highly 
occupied species is the strongly bound AMD complex (pale blue) which increase from 0.068 at 
[A] = D?௠ to 0.13 at [A] = 20 D?௠. 
Notably, the fraction of states that are strongly attached almost doubles from 0.073 to 
0.141 as the actin concentration increases from D?௠ to 20 D?௠.  This fraction of strongly attached 
states is equal to the duty ratio, D?D?, i.e. the fraction of the ATPase cycle during which a cross 
bridge is strongly attached.  This number then allows an estimate of the maximum velocity (in a 
motility assay or muscle shortening), D?௢, from  the equation  D?௢ ൌ D? D? ?  where D? is the myosin 
throw, i.e. the distance over which myosin can produce force, and D? is the lifetime of the  
attached state.  The lifetime of the attached state is equal to D?D?/ATPase rate (the ATPase rates 
are also listed in Table 4 for each actin concentration), hence D?௢ ൌ  D? ൈ D?D?D?D?D?D?D?D? ?    The 
calculated values of D?௢ are listed in Table 4 and show that for a working stroke of 5 nm the 
velocity is  ~0.20 µm.s-1
.
  The estimate of velocity is independent of the actin concentration 
above D?௠, which is  compatible with observations from the in vitro motility assays. 
It is also possible to estimate the effect of a load on the ATPase cycle of a single myosin 
motor and this will be considered in the discussion.  The model generates overall properties of 
WKHȕ-myosin isoform which are similar to those expected from contracting muscle fibers 
containing the isoform.  In the next section the same approach is developed for a set of well-
defined myosin isoforms. 
 Fast skeletal myosin S1 from the rabbit is the best biochemically defined fast muscle 
myosin and as illustrated in Fig 3A the fit of the model to the ATPase data was well defined.  
The resolution matrix indicated a similar quality of the fit (Table 3 and see Table S3 and Fig S1).   
The state occupancies are shown in Fig. 3B, Tables 4 and Table S2.  
A further isoform that we have FKDUDFWHUL]HGLVWKHKXPDQĮ-cardiac myosin (11), but this 
isoform has only been well defined at 100 mM KCl, i.e. at conditions where the actin 
dependence of the steady state ATPase cannot be measured with any precision.  The effect of salt 
on each of the steps of the ATPase cycle is well defined for the rabbit fast muscle myosin and 
KXPDQȕ-cardiac data as listed in the Table S1.    The differences between 25 and 100 mM KCl 
for the measured parameters are very similar for both proteins.  The major effect of KCl 
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concentration, apart from the expected change in actin affinity, is on the equilibrium constants of 
ATP binding  (D?் ) which is ~3 fold weaker at 100 mM KCl for both rabbit skeletal and human 
cardiac S1.  The effect on all other steps is modest in comparison.  The exception is the ADP 
affinity which is quite distinct for the two myosins; ADP binding is weak (120 µM) and 
relatively independent of KCl for rabbit fast muscle S1 while it is much tighter  and salt 
GHSHQGHQWIRUKXPDQȕ-myosin (~ 20 µM at 100 mM KCl; ~ 6 µM at 25 mM KCl).  On the 
assumption that Į-cardiac myosin is like rabbit fast muscle in its weak affinity for ADP the 100 
mM KCl values of rate and equilibrium constants can be corrected to 25 mM KCl as shown in 
Table S1 and the 25 mM KCl data are listed in Table 1. The reliability of the assumptions made 
here will be considered in the Discussion. The actin dependence of the ATPase data has been 
defined for several ĮP\RVLQ isoforms and, in general, the D?௠௔௫  of the ATPase and the velocity 
of shortening is about 2-WLPHVWKDWRIWKHȕ-isoform from the same species under the same 
experimental conditions (28).    6LQFHVHSDUDWLRQRISXUHĮDQGȕLVRIRUPVLVQRWVLPSOHZHKDYH
assumed a 3 fold difference in the D?௠௔௫  of the ATPase. We therefore repeated the modeling for 
WKHĮ-cardiac data with values of constants listed in Table 1.  Once again the ATPase data can be 
well defined with good definition of all fitted constants (Figs. 3A and S1; Tables 4, and S2). 
The R453C PXWDWLRQLQȕ-cardiac myosin is a classic severe hypertrophic myopathy 
mutation which, without intervention, results in 50% mortality rate in heterozygotic carriers of 
the mutation by the of age 40 (29):HGHILQHGWKHSURSHUWLHVRIWKLVPXWDWLRQLQWKHKXPDQȕ-
cardiac myosin motor domain by transient kinetics (10), and steady-state kinetics, single 
molecule and ensemble mechanical data were collected by collaborators (25).  The transient 
kinetic data were collected at 100 mM KCl and have been corrected to the 25 mM KCl ± as was 
GRQHIRUWKHĮ-cardiac data (see Table S1) and the fits to the ATPase data were once again very 
good  (Figs. 3A and  S1; Tables 4, and S2). 
With the model well-defined by the experimental data for the three myosin isoforms we 
can consider the details of the model and how each isoform differs in the state occupancy of each 
intermediate in the ATPase cycle, the predicted velocities, duty ratios and how these depend 
upon actin concentration.  There are many different comparisons to be drawn between the 
different data sets, only the major issues will be highlighted here and further consideration given 
to the isoform differences in the Discussion. Note that for these ATPase cycles the concept of a 
simple rate-limiting step does not apply, as has been recognized in enzymology for a number of 
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years.  Multiple states contribute to the overall balance of the cycle and small changes in any step 
can and will alter the balance of events in the cycle.  This is why understanding the role of 
individual point mutations in a myosin requires a detailed study of the cycle.  
$VVHHQIRUWKHȕ-cardiac myosin in all cases the state occupancies shift from detached 
(MT and MDPi) to attached states as the actin concentration increased.   Even though the actin 
concentrations used in the simulation result in the same degree of saturation of the ATPase 
velocity each myosin isoform has a distinct distribution of states. At [A] = D?௠ ( D? ൌ  ?Ǥ ?D?௠௔௫ ) 
the rabbit skeletal myosin has fractional occupation of  the  detached states as 0.58, weakly 
attached at 0.35 and strongly attached as 0.075 (note the values are rounded to 2 significant digits 
here, resulting in the total being less than 1).  Distributions within these categories are given in 
Table 4 and listed in more detail in Fig 3B and Table S2.   ȕ-cardiac myosin has identical state 
occupancy of the strongly attached state and hence the same duty ratio as the skeletal isoform, 
0.073, but there is a lower occupancy of the weakly attached states, 0.20.  This alteration is the 
balance of the cycle is caused by a reduction in the rate constants controlling both ADP release 
and ATP hydrolysis.  The two together result in a slower cycling speed and a retained duty ratio.  
But the slower hydrolysis step results in a greater occupancy of the MT complex and lower A-
MDPi.  In contrast,  WKHĮLVRIRUPKDVDKLJKHUGXW\UDWLR WKDQHLWKHUȕor skeletal 2A, 0.10, and a 
distribution between detached and weakly attached states similar to that of the skeletal isoform. 
As actin concentration increases the strongly attached states but the duty ratio remains the same 
for the VNHOHWDODQGȕisoforms, saturating at about 0.14 ZKLOHWKHĮLVRIRUPLVhigher at 0.19.  
1RWHWKHȕ-cardiac at 20Km actin has more than twice the fraction of detached states as the 
skeletal isoform due to the slower UDWHFRQVWDQWRIWKHK\GURO\VLVVWHSDQGZKLOHĮLVRIRUPLV
more similar to the skeletal isoform. 
$VIRUWKHȕisoform, the ATPase rates and the duty ratio can be used to estimate the 
unloaded shortening velocity.  From the data in Table 4, in each case the predicted velocity is 
LQGHSHQGHQWRIWKHDFWLQFRQFHQWUDWLRQDQGWKHĮLVRIRUPKDVDSUHGLFWHGYHORFLW\RI.45 µm/s 
for a 5 nm step more than twice that of the ȕLVRIRUP, 0.20 µm/s. The skeletal isoform has a 
velocity twice WKDWRIWKHĮLVRIRUP, 0.99 µm/s.   The relative values here are similar to those 
measured for the same myosin isoforms in motility assays however it is difficult to find 
measurements for all three isoforms under identical conditions. Absolute values do vary from 
laboratory to laboratory. Most recent values are collected at higher temperatures of ~30-35 °C 
15 
 
and velocity has a very marked temperature dependence (30, 31).   Values from the rat muscle 
LVRIRUPVJLYHPVIRUWKHVORZȕLVRIRUPDQG2.6 µm/s for the fast 2a isoform at 20 °C   
and ~5 times faster at 30 °C (31). The rat isoforms are expected to be two fold faster than the 
human isoforms with rabbit isoforms in between those of rat and human (32).  
The R453C mutation in human ȕ-cardiac myosin results in severe HCM. Our published 
analysis of this mutation (10) indicated that the major changes were a reduction in the rate 
constants of the ATP hydrolysis step (D?ு) and the isomerization controlling ADP release (D?஽כ).  
Putting these numbers into the model along with the ATPase data of Sommese et al. (25) gave 
the following predictions.  &RPSDUHGWRWKHZWȕGDWDWhe duty ratio was increased by ~ 59 % at 
each actin concentration while the predicted velocity of shortening was reduced by almost 50%.  
The increased duty ratio and slower velocity are both the result of the longer lifetime of the 
AMD state.  The longer lived AMD state results in a higher occupancy of the force holding 
(AMD) state and therefore predicts a higher force capacity for this mutation than for the wt.  This 
is compatible with measured single molecule force (increased by 50%), increased ensemble force 
and the reduced motility assay velocity (reduced by 36%) reported for this mutation by Sommese 
et al. (25).   
 
DISCUSSION 
Defining a precise ATPase cycle for muscle myosins is a first step towards developing an 
accurate multiscale model that can be used for interpreting single molecule mechanical 
measurements, motility assays, data from Ca2+ regulated ATPase models and contracting 
sarcomeres.   The advantage of having a well-defined  ATPase cycle is that the subsequent 
models are more highly constrained  allowing focus on the key additional processes, including 
the geometry of the available myosin binding sites on actin (see Mijailovich et al. (33)), the 
effect of load on individual motors or on an ensemble  and the modulation of the cycle events by 
regulatory systems.   Such a model is under construction (MUSICO (33-41)) but such a model 
needs good experimental data for each different muscle systems collected as nearly as possible 
under identical experimental conditions (ionic strength, temperature and etc.).  This is a 
challenge as ATPase assays, motility assays and muscle fiber mechanics all have their own 
preferred conditions.  Transient kinetics can be collected under most solution conditions 
16 
 
provided the proteins are stable over the time course of the measurement and at temperatures 
from zero to 40 °C (42).  
The experimental data used here for both human ȕ-cardiac and rabbit fast muscle myosin 
were collected under very similar conditions and, as seen, the predictions for duty ratio for these 
two isoforms give a very similar answer.   The R453C transient kinetic data were collected at a 
higher ionic strength than the ATPase data and then corrected to the lower ionic strength.  The 
similar effects of salt on the parameters for ZWȕ-cardiac and rabbit fast muscle suggest the 
corrections applied will be reasonably accurate.   This is particularly so as the R453 residue is 
not a surface exposed residue and therefore unlikely to be influenced directly by the solution 
ionic strength.    But confirming the R453C data at the lower ionic strength would be essential if 
the modeling of this mutant were to be taken further forward. Here the intention is to present the 
potential of this modeling approach.    
7KHGDWDIRUĮ-cardiac isoform has both the ionic strength corrections for the transient 
kinetic data and the ATPase data and were extrapolated from closely related studies.  This data is 
therefore of lower reliability.    Our primary reason for including it here is to emphasize the 
potential of the approach.  There are very few studies of the atrial myosin from any source and 
the Deacon et al. (11) work is the only transient kinetic study of the atrial isoform from human or 
any other source.    There are myofibril studies from atrial and ventricle tissue that 
predominanWO\H[SUHVVĮRUȕP\RVLQLVRIRUPVUHVSHFWLYHO\DQGVHYHUDOVWXGLHVRIDtrial and 
ventricular myosin ATPases and motilities have been reported (43-45). In any future detailed 
study of the atrial isoforms it would be helpful to match the experimental conditions to those 
used here to facilitate comparisons using this modeling approach. 
We use as far as possible strict criteria for including experimental data in our analysis i.e. 
that a single pure myosin isoforms were used in all experiments and the data were collected 
under the same experimental conditions of temperature and ionic strength.   Other comparative 
data exists which do not match the exact details.  Of significance is the work of White and a 
series of colleagues making a direct measure of the rate constant for  Pi release at saturating actin 
concentrations using  the phosphate binding protein (46, 47).   Under slightly different ionic 
strength condition they estimate Pi release to be 75-77 s-1 for rabbit S1 which is about twice our 
estimate of 45 s-16LPLODUPHDVXUHPHQWVRQSRUFLQHȕ-cardiac S1, a close DQDORJXHRIKXPDQȕ-
S1, estimates the Pi release to be 17 s-1 (48) which compares well with our estimate of 16 s-1.    
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Note however our fitting approach does show a co-dependence of  D?௉௜ on the rate of the ATP 
hydrolysis step D?ு.  In our current assays the measurement of Pi release requires larger quantities 
of protein than are currently accessible for the human proteins.  In general our analysis is in 
broad agreement with the studies of White and colleagues and indicates that both D?௉௜ and D?ு 
have a major influence on the D?௠௔௫  of the ATPase, the relative importance of each may vary with 
ionic strength and temperature.     
Comparisons of isoforms 
To a first approximation muscle fibers expressing a single myosin isoform differ 
markedly in the maximum velocity of contraction and much less so in the isometric force (when 
correction is made for the density of myofilaments in the muscle fibers (9, 49)).   Alongside this, 
single molecule studies of myosin II isoforms suggest little variation in the step size, duty ratio 
or force per crossbridge between muscle myosin II isoforms (44) suggesting little change in 
crossbridge stiffness between myosin isoforms.   Changes in contraction parameters between 
isoforms are therefore thought to be largely due to the velocity of the ATP drive cycle (the 
steady state ATPase cycle for an unloaded system), and how much load affects the cycle.   The 
data presented here illustrates how the unloaded systems changes for the three isoforms 
considered in terms of cycle speed and duty ratio and from which we can predict the unloaded 
velocity (from a motility assay or muscle fiber contraction).  We have also explored how a load 
might affect each cycle differently for a single myosin motor assuming no change in the 
crossbridge stiffness between isoforms. The load dependence of an ensemble of myosin motors 
could be subject to a variety of additional sources of compliance such as filament compliance. 
The data indicate, as expected, that all three myosin isoforms are low duty ratio motors. 
Rabbit skeletal and human ȕ-cardiac are almost identical in this respect with a duty ratio of 0.11 
at an actin concentration equivalent to 3D?௠7KHĮLVRIRUPLVVOLJKWO\higher at 0.15 but the 
difference is moderate and could be due to differences in the experimental conditions used and 
the corrections applied.  From the duty ratios and ATPase rates and a 5 nm step size the 
velocities were predicted and are compatible with those expected from experimental studies; 1-2  
µm/s for the fast muscle (for a 5-10 nm crossbridge throw)  DQGUHGXFHGE\IRUWKHĮ-
LVRIRUPDQGIRUWKHȕ-isoform (5, 44).  
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There have been two reports of the effect of load on the ADP release step from the ȕ-
isoform and both studies (12, 13) fitted their data to a model where the load dependence of the 
rate constant for ADP release D?ሺD?ሻ is defined by D?ሺD?ሻ ൌ D?௢ D?ሺିிڄఋ೏೐೟Ȁ௞ಳכ்ሻ 
where D?௢ is the rate constant for  ADP release in the absence of load, D? is the force on the 
crossbridge  and D?ௗ௘௧ is the distance to the transition state, D?஻ LV%ROW]PDQQ¶VFRQVWDQWDQGis 
the temperature. 
We took the simplest approach to examine how the cycle would be influenced by such a 
load on a single molecule (i.e. no cooperative effects that would apply in an ensemble system). 
We assumed, based on the single molecule measurements which give D?ௗ௘௧ as approximately 0.9 
nm, that a 5 pN load would reduce ADP release by a factor of 3.     For simplicity we applied the 
same 3 fold reduction in the rate constant for the force generating transition coupled to Pi release 
(D?௉௜ሻ. We assumed the same value of D?ௗ௘௧ for all three isoforms in order to evaluate how the 
cycle itself influences the load dependence of the isoforms.  Any change in D?ௗ௘௧ or of the 
stiffness of the crossbridge would be additive effects upon those illustrated here.  
The result for [A] = 3D?௠ (see Table 5) shows the load would have a very similar effect 
on the velocity for both cardiac isoforms falling by ~ 65% while for the fast muscle isoform the 
reduction is lower at 57%.  This is as expected from well-defined force velocity curves from 
individual muscle fibers where the contraction velocity of slow ȕ myosin muscle fibers has a 
greater sensitivity to load.   Interestingly, RXUGDWDSUHGLFWVWKDWWKHĮLVRIRUPKDVDYHU\VLPLODU
sensitivity of velocity to load but maintains an approximately 2 fold higher ATPase cycling rate 
thaQWKHȕ-isoform.  The effects on the ATPase cycling rates were different, Į-cardiac and the 
fast muscle isoform are inhibited to the same extent (-61.4 %) ZKLOHWKHȕLVRIRUPLVRQO\
slightly less inhibited by 56%.   This difference in the effect of load in the ATPase and velocity 
emphasizes the decoupling of ATPase and velocity cycles as first pointed out by White and 
collaborators (50). 
If the tightly bound ADP state AMD is considered as the primary force holding state then 
the HIIHFWRIORDGRQWKHRFFXSDQF\RIWKLVVWDWHLVRILQWHUHVW)RUWKHIDVWPXVFOHDQGWKHĮ-
cardiac myosin isoforms the load increases the fractional occupancy of this state by ~ 15 %  in 
both cases (from 0.074 and 0.135 in unloaded conditions respectively, see Tables 5 and S2) 
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ZKLOHWKHȕ-isoform occupancy increases by 32.5 %  (from 0.10) ± emphasizing  again the greater 
VHQVLWLYLW\RIWKHȕLVRIRUPWRORDG 
One of the clear results from the modeling is that the predicted velocity is independent of 
actin concentration.    This is a result of both the ATPase and the duty ratio having the same 
dependency on actin concentration thus  D?௢ ൌ  D? ൈ D?D?D?D?D?D?D?D? ?   is independent of actin 
concentration.  The actin dependence of the duty ratio results from the actin dependence of the 
cycling time ( = 1/ATPase)  while strongly attached lifetime D? is primarily controlled by ADP 
release rate constant and is independent of actin concentration.  Thus the velocity only depends 
upon the strongly attached lifetime and is independent of the actin dependent ATPase rate. 
In our modeling we used three different actin concentrations to explore how the balance 
of the cycle changes for different levels of actin activation.  This raises the question of the 
appropriate actin concentration for comparison with a myosin in the sarcomere.   Most models 
use an estimate for the fraction of myosin heads attached to actin (strongly bound or the sum of 
weak and strongly bound) in the contraction sarcomere.  These vary from 1-5% strongly attached 
crossbridges in a rapidly shortening muscle to ~20% under isometric conditions.   At the lowest 
concentrations modeled  ([A] = D?௠)  the estimate of strongly attached bridges is 7-10% without 
load for all three wt isoforms, and the weakly attached bridges vary from 20-35% for different 
isoforms.   Thus the averaJHDFWLQFRQFHQWUDWLRQ³VHHQ´E\DP\RVLQKHDGLQWKHVDUFRPHUH
would be of the order of the D?௠ value for actin while rapidly shortening.  Of course, individual 
myosin heads would be exposed to a wide range of apparent actin concentrations in an isometric 
fiber which is why we used the higher actin concentration of 3 D?௠ to model the effect of load. 
The load-bearing strongly attached heads are those that are most likely to bind actin at the 
specific filament overlap considered.  These issues will be considered further in the sarcomeric 
version of this model (MUSICO (33)). 
R453C 
:HLQFOXGHWKHGDWDIRURQHȕ-cardiac myosin mutation here to illustrate the potential power of 
the approach for dissecting the effect of point mutations on myosin activity.  R453C is a severe 
hypertrophic cardiomyopathy mutation and our published analysis (10) of this mutation indicated 
a significant reduction in the rate of ATP hydrolysis step (D?ு) and ADP release (D?஽כ).  Including 
these values into the model gave the following predictions.  The velocity was reduced by 47% 
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compare to wt while the duty ratio increased by 60% and the occupancy of the AMD state 
increased from 0.102 to 0.169, a 66% increase (Table 4 and S2).  Thus a muscle expressing only 
this isoform would be expected to contract more slowly and develop higher forces due the 
greater fraction of strongly attached force holding states.   The influence of load, with the same 
assumptions as for the wt protein show 65.7% reduction in velocity similar to the 65% reduction 
for the wt and a slightly smaller reduction in the ATPase rate of 55.7% (61 % for wt) while the 
occupancy of the AMD state  increased markedly by 32.8 % from 0.117 fraction occupancy   
compared to 32.5% for wt as shown in Table 5.  These numbers can be compared to the motility 
and single molecule data for this mutant from Sommese et al. (25).    They found that the single 
molecule force generation increased by 50% from 1.4 pN for the wt to 2.1 pN. This compares 
with our predicted 66% increase in the strongly attached AMD state or the 60% increase in duty 
ratio.    In the motility assay Sommese et al. (25) reported that the velocity was reduced by 24% 
from 0.8 µm/s from the wt to 0.61 µm/s and the velocity was more readily inhibited by a load 
using an actin cross-linker.  Our data suggest a larger 47% reduction in velocity compared to wt 
and while velocity is reduced by a similar percentage (65%) by a load of 5 pN for wt and R453C.  
The data used here is all referenced to 25 mM KCl ± lower than that found in a muscle 
fiber.  The transient kinetic data in table S1 indicates how some of these steps are affected by salt 
but estimating salt effects on the actin affinity and Pi release steps remain inaccessible to 
solution measurements at physiological ionic strengths. Even some motility assays and single 
molecule assays are best performed at low salt because of the low probability of a cross bridge 
being bound to actin at the higher ionic strengths.    Muscle fiber or myofibril studies provide 
information concerning these events but the assays report on ensemble behavior and are affected 
by the 3D geometry of the filaments.  These require a different modeling approach (33), which is 
under development, but having the majority of the ATPase cycle well defined puts limits on the 
remaining variables in such models. 
What we have demonstrated here is that studies of the unloaded solution ATPase cycle 
can define the properties of myosin isoforms and of mutations in the motor domain.  Studies 
allow predictions and set limits on the mechanical behavior of each isoform.  Each of the 
isoforms studied here has a specific relationship between the cycle and the predicted mechanical 
events which can define some of the properties of the contracting muscle fiber such as maximum 
velocity and load sensitivity.   In the next stage of developing our multilevel modeling package 
(MUSICO) we will examine how the properties of the individual myosin isoforms defined here 
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modulate the calcium regulation of the thin filament and the mechanical properties of a 
contracting sarcomere.   For example, the differences in the number and lifetimes of the strongly 
attached AMD cross-bridge for each isoform might be expected to influence the switching 
between on and off states of the thin filament.  
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FIGURE 1  A minimal ATPase actin-myosin cycle is defined by eight states and nine 
equilibrium constants. The actin monomers, A, along an actin filament are shown as three green 
filled circles and the motor domain of myosin, M, is represent as two ellipses, the large 
representing the upper and lower 50 k domain with a cleft separating the two. The smaller ellipse 
represents the converter domain with a rectangular lever arm.  The relative movements of these 
domains represent the structural conformations of myosin in each state. The actin-myosin cycle 
includes ATP binding to rigor-like complex, AM, forming the AMT state (equilibrium constant 
for the transition D?் = [AMT]/[AM][T]) followed by a rapid change in myosin conformation 
leading to the cleft opening in the A-MT state ( D?் כ) and followed by rapid detachment of actin 
(D?்ככ).  A conformation change in the head following the opening of the 50 kDa cleft leads to the 
recovery stroke and hydrolysis of ATP transitioning into the MDPi state (D?ு).  Then, the myosin 
can reattach to actin forming A-MDPi state (D?஺) and after the cleft closure, the power stroke and 
Pi release transitioning into an AMD state (D?௉௜) in which ADP remains firmly attached to 
myosin.  This state allows a conformational change into the AM-D state (D?஽כ) from which ADP 
is released (D?஽) and the cycle is completed.   The step labelled D?஺ு  allows for possible 
hydrolysis ATP while myosin remains attached to actin.  For simplicity, ATP and ADP in state 
labeling are denoted as T and D, respectively, inorganic phosphate as Pi, and a hyphen indicates 
relatively weak association between the species. The equilibrium constants between the states are 
denoted in green letters and represent a ratio between forward (clockwise) and reverse state 
transition rate constants. Note the nomenclature for rate and equilibrium constants uses the 
subscript ( A, D, Pi, T)  to indicate the species binding or released from myosin in each 2nd order 
step.  A star (*) indicates that it is an isomerisation event linked with the 2nd order binding or 
dissociation event.  The only exception is D?ு and D?஺ு which are the ATP hydrolysis steps with 
or without actin attached.    
 
FIGURE 2  0RGHOLQJWKH$73DVHF\FOHIRUȕ-cardiac myosin.  (A) The best fit of ATP-ase vs. 
DFWLQFRQFHQWUDWLRQ>$@RI+&:7ȕ- S1.  Data in black are the predicted ATPase rates based on 
the published D?௠௔௫  and D?௠ values and the red data are the best fit of the model in Fig. 1 to the 
data.  The constants used and derived in the fitting are listed in Table 1.   The state occupancies 
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for each of the intermediates in the cycle are given in a pie chart, color coded to match the 
intermediates in Fig 1.   These are shown for 3 actin concentration (blue diamonds) at [A] = D?௠, 
3D?௠,  20D?௠  and at 3D?௠ under load ± see text. B) The convergence of the equilibrium constants,  D?஺,  D?ு, ,  D?஺ு, and reverse rate constants,  D?ି௉௜, and ,  D?ି்,  by DLS  for the damping parameter 
İ (21). All free parameters converge at 30 to 50 iterations except D?ି் where value varies 
between 3200 and 3350 s-1 but, however, this variation does not affect the error suggesting that 
the value of this parameter cannot be resolved for this experiment (see Table 1).  The mean 
square error (21) converges quickly to a normalized value, Error =ඥԡԡଶଶ D? ? <2¯10-6 s-1, and fit 
of data is excellent. The resolution matrix for this fitting procedure is listed in Table 2. 
FIGURE 3  The details of the fit to the ATPase data (A) and the state occupancy of intermediates 
in the ATPase cycle (B) for four muscle myosin isoforms. A) The dependence of the ATPase 
cycle on actin concentration and B) the occupancy of each of the intermediates in the ATPase 
cycle at three different actin concentrations [A] =D?௠, 3D?௠ and 20 D?௠  corresponding to 0.5, 0.75 
and 0.95 of D?௠௔௫ . The presentation also includes predictions for how the state occupancy would 
change for the [A] = 3D?௠ conditions if the actomyosin system were loaded such that  the 
isomerization steps controlling both Pi and ADP release were reduced by a factor of  3 (see text 
for details).  The values generated for the pie charts are given in Table S2. 
Note:  Low actin concentration state occupancies were dominated by MDPi  (range 0.40 to 0.45)  
and to a lesser extent by A-MDPi  (0.19-0.32). The MT form was more variable (0.13-0.29) 
reflecting the wide variation in the rate constant of the ATP hydrolysis step (D?ு).  As actin 
increased, there was a shift in occupancy from MDPi to A-MDPi as expected with MDPi almost 
negligible at [A] =20D?௠.  A-MDPi dominates (0.35-0.62) at [A] = 20D?௠ but with significant 
contributions from both MT (0.06-0.26) and A-MT (0.14-0.21).   The presence of a large amount 
of A-MT is due to the value of the weak affinity of MT for actin here assigned to 1 mM at 25 
mM KCl and expected to be 3 times weaker at 100 mM KCl.  Thus the A-MT would only be 
significant in a sarcomere if the local actin concentration exceeded 1mM at physiological salt 
concentrations.  The occupancy of MT is much larger in beta than in alpha and skeletal isforms 
reflecting the slower hydrolysis rate constant for beta.  The major form tightly bound to actin 
was AMD and this had a higher occupancy in beta and alpha than in skeletal myosin at all actin 





1. Lymn, R. W., and E. W. Taylor. 1971. Mechanism of adenosine triphosphate hydrolysis 
by actomyosin. Biochemistry 10:4617-4624. 
2. Trentham, D. R., J. F. Eccleston, and C. R. Bagshaw. 1976. Kinetic analysis of ATPase 
mechanisms. Quarterly reviews of biophysics 9:217-281. 
3. Geeves, M. A. 1991. The dynamics of actin and myosin association and the crossbridge 
model of muscle contraction. The Biochemical journal 274 ( Pt 1):1-14. 
4. Bloemink, M. J., J. C. Deacon, D. I. Resnicow, L. A. Leinwand, and M. A. Geeves. 2013. 
The superfast human extraocular myosin is kinetically distinct from the fast skeletal IIa, 
IIb, and IId isoforms. The Journal of biological chemistry 288:27469-27479. 
5. Resnicow, D. I., J. C. Deacon, H. M. Warrick, J. A. Spudich, and L. A. Leinwand. 2010. 
Functional diversity among a family of human skeletal muscle myosin motors. 
Proceedings of the National Academy of Sciences of the United States of America 
107:1053-1058. 
6. Bloemink, M. J., and M. A. Geeves. 2011. Shaking the myosin family tree: biochemical 
kinetics defines four types of myosin motor. Seminars in cell & developmental biology 
22:961-967. 
7. De La Cruz, E. M., and E. M. Ostap. 2004. Relating biochemistry and function in the 
myosin superfamily. Current opinion in cell biology 16:61-67. 
8. Heissler, S. M., and J. R. Sellers. 2016. Kinetic Adaptations of Myosins for Their Diverse 
Cellular Functions. Traffic 17:839-859. 
9. Bottinelli, R., and C. Reggiani. 2000. Human skeletal muscle fibres: molecular and 
functional diversity. Progress in biophysics and molecular biology 73:195-262. 
10. Bloemink, M., J. Deacon, S. Langer, C. Vera, A. Combs, L. Leinwand, and M. A. 
Geeves. 2014. The hypertrophic cardiomyopathy myosin mutation R453C alters ATP 
binding and hydrolysis of human cardiac beta-myosin. The Journal of biological 
chemistry 289:5158-5167. 
11. Deacon, J. C., M. J. Bloemink, H. Rezavandi, M. A. Geeves, and L. A. Leinwand. 2012. 
Erratum to: Identification of functional differences between recombinant human alpha 




12. Greenberg, M. J., H. Shuman, and E. M. Ostap. 2014. Inherent force-dependent 
properties of beta-cardiac myosin contribute to the force-velocity relationship of cardiac 
muscle. Biophysical journal 107:L41-44. 
13. Sung, J., S. Nag, K. I. Mortensen, C. L. Vestergaard, S. Sutton, K. Ruppel, H. Flyvbjerg, 
and J. A. Spudich. 2015. Harmonic force spectroscopy measures load-dependent kinetics 
of individual human beta-cardiac myosin molecules. Nature communications 6:7931. 
14. Smith, D. A., and M. A. Geeves. 1995. Strain-dependent cross-bridge cycle for muscle. 
Biophysical journal 69:524-537. 
15. Smith, D. A., and M. A. Geeves. 1995. Strain-dependent cross-bridge cycle for muscle. 
II. Steady-state behavior. Biophysical journal 69:538-552. 
16. Mijailovich, S. M., J. P. Butler, and J. J. Fredberg. 2000. Perturbed equilibria of myosin 
binding in airway smooth muscle: bond-length distributions, mechanics, and ATP 
metabolism. Biophysical journal 79:2667-2681. 
17. Johnson, K. A., Z. B. Simpson, and T. Blom. 2009. FitSpace explorer: an algorithm to 
evaluate multidimensional parameter space in fitting kinetic data. Analytical 
biochemistry 387:30-41. 
18. Johnson, K. A., Z. B. Simpson, and T. Blom. 2009. Global kinetic explorer: a new 
computer program for dynamic simulation and fitting of kinetic data. Analytical 
biochemistry 387:20-29. 
19. Otto, M. R., M. P. Lillo, and J. M. Beechem. 1994. Resolution of multiphasic reactions 
by the combination of fluorescence total-intensity and anisotropy stopped-flow kinetic 
experiments. Biophysical journal 67:2511-2521. 
20. Wong, E. V., W. Cao, J. Voros, M. Merchant, Y. Modis, D. D. Hackney, B. Montpetit, 
and E. M. De La Cruz. 2016. P(I) Release Limits the Intrinsic and RNA-Stimulated 
ATPase Cycles of DEAD-Box Protein 5 (Dbp5). Journal of molecular biology 428:492-
508. 
21. Mijailovich, S. M., X. Li, J. C. Del Alamo, R. H. Griffiths, V. Kecman, and M. A. 
Geeves. 2010. Resolution and uniqueness of estimated parameters of a model of thin 
filament regulation in solution. Comput. Biol. Chem. 34:19-33. 
22. Menke, W. 1989. Geophysical Data Analysis: Discrete Inverse Theory. Academic Press, 
Inc., San Diego, CA. 
26 
 
23. Swenson, A. M., D. V. Trivedi, A. A. Rauscher, Y. Wang, Y. Takagi, B. M. Palmer, A. 
Malnasi-Csizmadia, E. P. Debold, and C. M. Yengo. 2014. Magnesium modulates actin 
binding and ADP release in myosin motors. The Journal of biological chemistry 
289:23977-23991. 
24. Nag, S., R. F. Sommese, Z. Ujfalusi, A. Combs, S. Langer, S. Sutton, L. A. Leinwand, M. 
A. Geeves, K. M. Ruppel, and J. A. Spudich. 2015. Contractility parameters of human 
beta-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of 
motor function. Science advances 1:e1500511. 
25. Sommese, R. F., J. Sung, S. Nag, S. Sutton, J. C. Deacon, E. Choe, L. A. Leinwand, K. 
Ruppel, and J. A. Spudich. 2013. Molecular consequences of the R453C hypertrophic 
cardiomyopathy mutation on human beta-cardiac myosin motor function. Proceedings of 
the National Academy of Sciences of the United States of America 110:12607-12612. 
26. Sleep, J. A., and R. L. Hutton. 1980. Exchange between inorganic phosphate and 
adenosine 5'-triphosphate in the medium by actomyosin subfragment 1. Biochemistry 
19:1276-1283. 
27. Stein, L. A., P. B. Chock, and E. Eisenberg. 1981. Mechanism of the actomyosin 
ATPase: effect of actin on the ATP hydrolysis step. Proceedings of the National 
Academy of Sciences of the United States of America 78:1346-1350. 
28. Malmqvist, U. P., A. Aronshtam, and S. Lowey. 2004. Cardiac myosin isoforms from 
different species have unique enzymatic and mechanical properties. Biochemistry 
43:15058-15065. 
29. Watkins, H., A. Rosenzweig, D. S. Hwang, T. Levi, W. McKenna, C. E. Seidman, and J. 
G. Seidman. 1992. Characteristics and prognostic implications of myosin missense 
mutations in familial hypertrophic cardiomyopathy. The New England journal of 
medicine 326:1108-1114. 
30. Anson, M. 1992. Temperature dependence and Arrhenius activation energy of F-actin 
velocity generated in vitro by skeletal myosin. Journal of molecular biology 224:1029-
1038. 
31. Canepari, M., M. Maffei, E. Longa, M. Geeves, and R. Bottinelli. 2012. Actomyosin 
kinetics of pure fast and slow rat myosin isoforms studied by in vitro motility assay 
approach. Experimental physiology 97:873-881. 
27 
 
32. Pellegrino, M. A., M. Canepari, R. Rossi, G. D'Antona, C. Reggiani, and R. Bottinelli. 
2003. Orthologous myosin isoforms and scaling of shortening velocity with body size in 
mouse, rat, rabbit and human muscles. The Journal of physiology 546:677-689. 
33. Mijailovich, S. M., O. Kayser-Herold, B. Stojanovic, D. Nedic, T. C. Irving, and M. A. 
Geeves. 2016. Three-dimensional stochastic model of actin-myosin binding in the 
sarcomere lattice. The Journal of general physiology 148:459-488. 
34. Geeves, M., H. Griffiths, S. Mijailovich, and D. Smith. 2011. Cooperative [Ca(2)+]-
dependent regulation of the rate of myosin binding to actin: solution data and the 
tropomyosin chain model. Biophysical journal 100:2679-2687. 
35. Smith, D. A., M. A. Geeves, J. Sleep, and S. M. Mijailovich. 2008. Towards a unified 
theory of muscle contraction. I: foundations. Ann Biomed Eng 36:1624-1640. 
36. Smith, D. A., and S. M. Mijailovich. 2008. Toward a unified theory of muscle 
contraction. II: predictions with the mean-field approximation. Ann Biomed Eng 
36:1353-1371. 
37. Mijailovich, S. M., O. Kayser-Herold, X. Li, H. Griffiths, and M. A. Geeves. 2012. 
Cooperative regulation of myosin-S1 binding to actin filaments by a continuous flexible 
Tm-Tn chain. Eur Biophys J 41:1015-1032. 
38. Mijailovich, S. M., X. Li, R. H. Griffiths, and M. A. Geeves. 2012. The Hill model for 
binding myosin S1 to regulated actin is not equivalent to the McKillop-Geeves model. 
Journal of molecular biology 417:112-128. 
39. Prodanovic, M., T. C. Irving, and S. M. Mijailovich. 2016. X-ray diffraction from 
nonuniformly stretched helical molecules. J Appl Crystallogr 49:784-797. 
40. Mijailovich, S. M., O. Kayser-Herald, R. L. Moss, and M. A. Geeves. 2009. Thin 
Filament Regulation of Relaxation in 3D Multi-Sarcomere Geometry Biophys  J 96:201a 
(Abstract). 
41. Mijailovich, S. M., B. Stojanovic, D. Nedic, and M. A. Geeves. 2015. Activation and 
Relaxation Kinetics in Skeletal and Cardiac Muscles. Biophysical journal 108:337a-338a. 
42. Walklate, J., and M. A. Geeves. 2015. Temperature manifold for a stopped-flow machine 
to allow measurements from -10 to +40 degrees C. Analytical biochemistry 476:11-16. 
43. Piroddi, N., A. Belus, B. Scellini, C. Tesi, G. Giunti, E. Cerbai, A. Mugelli, and C. 
Poggesi. 2007. Tension generation and relaxation in single myofibrils from human atrial 
28 
 
and ventricular myocardium. Pflugers Archiv : European journal of physiology 454:63-
73. 
44. Palmiter, K. A., M. J. Tyska, D. E. Dupuis, N. R. Alpert, and D. M. Warshaw. 1999. 
Kinetic differences at the single molecule level account for the functional diversity of 
rabbit cardiac myosin isoforms. The Journal of physiology 519 Pt 3:669-678. 
45. Narolska, N. A., S. Eiras, R. B. van Loon, N. M. Boontje, R. Zaremba, S. R. Spiegelen 
Berg, W. Stooker, M. A. Huybregts, F. C. Visser, J. van der Velden, and G. J. Stienen. 
2005. Myosin heavy chain composition and the economy of contraction in healthy and 
diseased human myocardium. Journal of muscle research and cell motility 26:39-48. 
46. White, H. D., B. Belknap, and M. R. Webb. 1997. Kinetics of nucleoside triphosphate 
cleavage and phosphate release steps by associated rabbit skeletal actomyosin, measured 
using a novel fluorescent probe for phosphate. Biochemistry 36:11828-11836. 
47. Heeley, D. H., B. Belknap, and H. D. White. 2002. Mechanism of regulation of 
phosphate dissociation from actomyosin-ADP-Pi by thin filament proteins. Proceedings 
of the National Academy of Sciences of the United States of America 99:16731-16736. 
48. Liu, Y., H. D. White, B. Belknap, D. A. Winkelmann, and E. Forgacs. 2015. Omecamtiv 
Mecarbil modulates the kinetic and motile properties of porcine beta-cardiac myosin. 
Biochemistry 54:1963-1975. 
49. Schiaffino, S., and C. Reggiani. 2011. Fiber types in mammalian skeletal muscles. 
Physiological reviews 91:1447-1531. 
50. Siemankowski, R. F., M. O. Wiseman, and H. D. White. 1985. ADP dissociation from 
actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in 
vertebrate muscle. Proceedings of the National Academy of Sciences of the United States 




 TABLE 1   Rate and equilibrium constants used for modeling the ATPase cycle. 
Equilibrium 
Rate Const. Units 
Fast 
Skeletal 
HC WT  
E-S1 




Km  101.0 39.55 67.8 28.0 
Vmax  29.3 5.94 18.0 5.0 
      ࡷ࡭ P0 0.008 0.0107 0.011 0.012 ࡷࡼ࢏ m0 100.0 100.0 100.0 100.0 ࡷࡰ P0 100.0 36.00 197.0 33.3 ࡷࡰכ  í 50.0 0.167 50.0 0.050 ࡷࢀ P0 0.005 0.003 0.004 0.003 ࡷࢀכ  í 1507 154.0 150.0 150.0 ࡷࢀככ  P0 1000 1000 1000 1000 ࡷࡴ í 10.22 8.9136 4.061 7.419 ࡷ࡭ࡴ í 75.15 63.145 52.76 150.3 
 
 
    
 
Forward 


















[ATP]  = 5mM ,    [ADP] = [Pi] = 0 mM    (standard initial rate ATPase conditions). 
Numbers in bold (black) were obtained from fits to the ATPase data shown in Fig 2A 
& 3A.  The rest of the values were assigned as described in the methods section. Bold 
gray numbers are calculated from fitted values in bold black.  
Backward 









      ࢑ି࡭ s 500 1000 1000 1000 ࢑ିࡼ࢏ m0 s 0.452 0.159 0.321 0.176 ࢑ିࡰ P0 s 10.0 27.80 10.0 30.3 ࢑ିࡰכ  s 6.0 354.0 2.0 794.0 ࢑ିࢀ s 1557 3349 6597 3350 ࢑ିࢀכ  s 1.0 10.0 12.0 10.0 ࢑ିࢀככ  P0 s 1.0 1.0 1.0 1.0 ࢑ିࡴ s 14.0 1.4 19.0 1.4 ࢑ି࡭ࡴ s 2.0 0.2 1.50 0.07 
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HC WT E S1  ࡷ࡭ ࢑ିࡼ࢏ ࢑ିࢀ ࡷࡴ ࡷ࡭ࡴ 
         ࡷ࡭ 0.0107 PM-1 0.9092 0.3125 -0.0001 -0.2264 -0.2320 ࢑ିࡼ࢏ 0.159 s-1mM-1 0.3125 0.9586 0.0001 0.2510 0.2524 ࢑ିࢀ 3349 s-1 -0.0001 0.0001 1.4×10-6 0.0002 0.0002 ࡷࡴ 8.91  -0.2264 0.2510 0.0002 0.8109 -0.1840 ࡷ࡭ࡴ  63.14  -0.2320 0.2524 0.0002 -0.1840 0.8117 





TABLE 3  The resolution matrix diagonal values, ࡾࢊ,  for each of the  
isoforms.  Full tables are in the Supporting Material 
 
 
Units Fast Skeletal 
HC WT  
E-S1 




      ࡾࢊሺࡷ࡭ሻ í 0.981 0.909 0.993 0.966 ࡾࢊሺ࢑ିࡼ࢏ሻ í 0.953 0.959 0.997 0.910 ࡾࢊሺ࢑ିࢀሻ í 2.5×10-6 1.4×10-6 2.3×10-6 0.15×10-6 ࡾࢊሺࡷࡴሻ í 0.849 0.811 0.960 0.856 ࡾࢊሺࡷ࡭ࡴሻ í 0.813 0.812 0.981 0.858 
 
 
    
Error s 7.050×10-6 1.430×10-6 7.060×10-6 2.310×10-6 
 
 







TABLE 4  Effect of actin concentration on the fractional occupancy  













Detached = MT & MDPi,   weakly attached = A-MT + A-MDPi, strongly  
attached = duty ratio DR = AMD + AM-D + AM + AMT.    













(µm s-1)  
 
      
Fast Skeletal       
 [A]= Km = 101 PM 14.7353 0.5775 0.3478 0.0747 0.0747 0.9862 
 [A]= 3Km 22.0896 0.3498 0.5382 0.1120 0.1120 0.9860 
 [A]= 20Km 28.0331 0.1049 0.7529 0.1422 0.1422 0.9857 
 
      
+&:7ȕ- S1       
[A]= Km = 39.55 PM 2.9744 0.7263 0.2002 0.0734 0.0734 0.2023 
[A]=3Km 4.4614 0.5655 0.3241 0.1103 0.1103 0.2021 
[A]=20Km 5.6619 0.2984 0.5606 0.1410 0.1410 0.2008 
 
      
+&:7Į- S1       
 [A]= Km = 67.8 M 9.0033 0.5985 0.3013 0.1001 0.1001 0.4497 
 [A]=3Km 13.5034 0.3820 0.4676 0.1504 0.1504 0.4489 
 [A]=20Km 17.1395 0.1355 0.6732 0.1914 0.1914 0.4477 
 
      
+&5&ȕ- S1       
 [A]= Km = 28 PM  2.5013 0.7298 0.1528 0.1174 0.1174 0.1065 
 [A]=3Km 3.7525 0.5769 0.2468 0.1763 0.1763 0.1064 






TABLE 5 Predicted effect of load on the ATPase cycle when the actin concentration is 3ࡷ࢓ 
Detach/weak att/strong att ± show fractional occupancy for detached, weakly attached and strongly attached 
sates. 
Duty ratio ± fraction   of strongly attached myosins/total myosin heads. 
ǻ±  % change in the parameter described on applying a load.  
 
  














Fast Skeletal          
 [A]= 3Km 22.0896 0.3498 0.5382 0.1120 0.1120 0.9860    
 [A]= 3Km - loaded 8.5232 0.3130 0.5866 0.1004 0.1004 0.4245 15.75 -56.9 -61.4 
          
+&:7ȕ- S1          
[A]=3Km 4.4614 0.5655 0.3241 0.1103 0.1103 0.2021    
[A]=3Km - loaded 1.9720 0.4677 0.3930 0.1393 0.1393 0.0708 32.52 -64.9 -55.7 
          
+&:7Į- S1          
 [A]=3Km 13.5034 0.3820 0.4676 0.1504 0.1504 0.4489    
 [A]=3Km - loaded 5.1737 0.3305 0.5082 0.1612 0.1612 0.1605 14.94 -64.2 -61.4 
          
+&5&ȕ- S1          
 [A]=3Km 3.7525 0.5769 0.2468 0.1763 0.1763 0.1064    
 [A]=3Km - loaded 1.6619 0.4714 0.3003 0.2283 0.2283 0.0364     32.84 -65.7 -55.7 







































































































































































































Units Fast Skeletal 
25 mMKCl   100 mM KCl 
HC WT E 
25 mM KCl     100 mM KCl 
 HC WT* D 
25 mM KCl 
HC WT D 
100 mM KCl 
E-R453C*  
25 mM KCl 
ȕ-R453C 
100 mM KCl ࡷ࡭ m0 7.08 2.0 10.7 4.0 ? 11.30 ? 14.35 ࡷࡼ࢏ m0 100 ? 100 ? ? 100 ? 100 ࡷࡰ P0 100 120 36 170 197 152 33 100.00 ࡷࡰכ í 50 50 0.1667 0.14 50 83.33 0.05 0.046 ࡷࢀ m0 5 1.92 3 0.88 4.1 1.6 3.2 1.1 ࡷࢀכ í 1507 1250 154.30 144 150.00 150.00 150 124.80 ࡷࢀככ P0 1000 1000 1000 1000 1000 1000 1000 1000 ࡷࡴ í 5 5.5 8.91 5.6 5 8.52 1.8 2.86 ࡷ࡭ࡴ í 61.77 ? 63.14  63.3 99.60 ? 124.43 ࡷ࢓ µM 101.01 - 39.553 - 67.8  284  ࢂ࢓ࢇ࢞ s-1 29.31 - 5.943 - 18  54  
 
 
        
Forward Rate Constants       
          ࢑࡭ P0s 3.54 1 10.75 4 ? 11.30 ? 14.35 ࢑ࡼ࢏ s 49.67 ? 15.95 ? ? 27.20 ? 14.69 ࢑ࡰ s 1000 1200 1000 1000 1970 1520 1000 1000 ࢑ࡰכ s 300 300 59.00 93 100 100.00 39.69 63.00 ࢑ࢀ P0 s 7.7 10 10.00 3.33 27.2 10.51 10 3.3 ࢑ࢀכ s 1507 1250 1543 1445 1800 1500 1500 1248 ࢑ࢀככ s 1000 1000 1000 1000 1000 1000 1000 1000 ࢑ࡴ s 70 110 12.47 14 95.1 143.16 2.52 4 ࢑࡭ࡴ s 123.54 ? 12.63 ?  149.40  8.71 
 
 
        
Backward Rate Constants       
          ࢑ି࡭ s 500 500 1000 1000  1000 ? 1000 ࢑ିࡼ࢏ m0 s 0.5 0.5 0.15   0.27 ? 0.15 ࢑ିࡰ P0 s 10 10 27.8 5.9 10 10 30.3 10 ࢑ିࡰכ s 6 6 354 650  1.20 794 1369 ࢑ିࢀ s 1540 5208 3349 3784 6500 6541.53 3125 3000 ࢑ିࢀכ s 1 1 10 10 12 10 10 10.00 ࢑ିࢀככ P0 s 1 1 1 1 1 1 1 1 ࢑ିࡴ s 14 20 1.4 2.5 19 16.8 1.4 1 ࢑ି࡭ࡴ s 2 ? 0.2 ? ? 1.5 ? 0.07 
39 
 
For the ATPase assays  
[ATP]  = 5mM ,    [ADP] = [Pi] = 0 mM    (standard initial rate ATPase conditions). 
[S1] =  1 µM  with varied [actin].    
Conditions: 25 mM KCl, 20 mM MOPS, 5 mM MgCl2 unless otherwise stated.  
 
Source of Data  
Bold allowed to vary in the fit to ATPase data 
X  Assumed diffusion limited: 
X Assumed min/max value 
X From detailed balance D?௜ ൌ D?௜ȀD?ି௜  
X From transients   
X from ATPase data reference: 
 
1%WKHGDWDIRU+&Į:7DQG5&DWP0.&OLVHVWLPDWHGIURPWKHP0GDWDDQGWKH.&OGHSHQGHQFHRIWKH
valued for the rabbit fast and HC-ȕPXVFOHLVRIRUPV 
1: Swenson, A.M., Trivedi, D.V., Rauscher, A.A., Wang, Y., Takagi, Y., Palmer, B.M., Málnási-Csizmadia, A., Debold, 
E.P., Yengo, C. M. Magnesium modulates actin binding and ADP release in myosin motors. The Journal of Biological 
Chemistry, 2014, 289 (34) pp 23977-91. 
IIa from rabbit 
2: Nyitrai, M., Rossi, R., Adamek, N., Pellegrino, M.A., Bottinelli, R., Geeves, M. A. What limits the velocity of 
fast-skeletal muscle contraction in mammals? Journal of Molecular Biology, 2006, 355 (3) 432-42 
This work gives values of D?ଶ  (= 740 s-1) and  ?ȀD?்  (= 520 µM) at 12 C. The value of  ?ȀD?்  is independent of 
temperature so the value of D?ଶ  at 20 C can be estimated from the D?் D?ଶ value at 20 C. Thus D?் D?ଶ= 2.4 uM-1s-1 where D?்
 
= 0.00192 µM and D?ଶ  = 1,248 s-1. 
3: Nag, S., Sommese, R.F., Ujfalusi, Z., Combs, A., Langer, S., Sutton, S., Leinwand, L. A., Geeves, M. A., 
Ruppel, K. M., Spudich, J. A. Contractility parameters of human ȕ-cardiac myosin with the hypertrophic 
cardiomyopathy mutation R403Q show loss of motor function. Sci Adv. 2015 Oct 9;1(9):e1500511. doi: 
10.1126/sciadv.1500511 
4: Sommese R.F., Sung J., Nag S., Sutton S. Deacon J.C.Choe E., Leinwand L.A., Ruppel K., Spudich J.A. Molecular 
consequences of the R453C hypertrophic cardiomyopathy mutation on human ȕ-cardiac myosin motor function.  Proc Natl 






Table S2  State occupancies of intermediates in the crossbridge cycle for the four myosins used here as a function of actin 




                












               
Fast Skeletal                
 [A]= Km = 101 PM 0.3234 0.0494 0.0147 0.0008 0.0098 0.0244 0.1260 0.4515 14.7353 0.5775 0.3478 0.0747 0.0747  0.9862 
 [A]= 3Km 0.4848 0.0741 0.0221 0.0012 0.0147 0.0534 0.1269 0.2229 22.0896 0.3498 0.5382 0.1120 0.1120  0.9860 
 [A]= 20Km 0.6152 0.0940 0.0280 0.0015 0.0187 0.1377 0.0639 0.0410 28.0331 0.1049 0.7529 0.1422 0.1422  0.9857 
 [A]= 3Km - loaded 0.5611 0.0857 0.0085 0.0004 0.0057 0.0255 0.0649 0.2481 8.5232 0.3130 0.5866 0.1004 0.1004 15.75 0.4245 
                
 
               +&:7ȕ- S1                
[A]= Km = 39.55 PM 0.1865 0.0683 0.0030 0.0002 0.0020 0.0138 0.2779 0.4484 2.9744 0.7263 0.2002 0.0734 0.0734  0.2023 
[A]=3Km 0.2797 0.1024 0.0045 0.0003 0.0032 0.0444 0.3423 0.2232 4.4614 0.5655 0.3241 0.1103 0.1103  0.2021 
[A]=20Km 0.3550 0.1299 0.0057 0.0004 0.0050 0.2056 0.2562 0.0422 5.6619 0.2984 0.5606 0.1410 0.1410  0.2008 
[A]=3Km - loaded 0.3707 0.1357 0.0020 0.0001 0.0014 0.0224 0.1744 0.2933 1.9720 0.4677 0.3930 0.1393 0.1393 32.52 0.0708 
                
 
               +&:7Į- S1                
 [A]= Km = 67.8PM 0.2801 0.0901 0.0046 0.0003 0.0051 0.0212 0.1988 0.3997 9.0033 0.5985 0.3013 0.1001 0.1001  0.4497 
 [A]=3Km 0.4201 0.1352 0.0069 0.0005 0.0078 0.0475 0.1833 0.1987 13.5034 0.3820 0.4676 0.1504 0.1504  0.4489 
 [A]=20Km 0.5333 0.1716 0.0087 0.0006 0.0105 0.1399 0.0982 0.0373 17.1395 0.1355 0.6732 0.1914 0.1914  0.4477 
 [A]=3Km - loaded 0.4829 0.1554 0.0026 0.0002 0.0030 0.0253 0.1058 0.2247 5.1737 0.3305 0.5082 0.1612 0.1612 14.94 0.1605 
                
                +&5&ȕ- S1                
 [A]= Km = 28 PM  0.1423 0.1130 0.0025 0.0002 0.0017 0.0105 0.2904 0.4394 2.5013 0.7298 0.1528 0.1174 0.1174  0.1065 
 [A]=3Km 0.2134 0.1696 0.0038 0.0002 0.0027 0.0334 0.3584 0.2185 3.7525 0.5769 0.2468 0.1763 0.1763  0.1064 
 [A]=20Km 0.2707 0.2151 0.0048 0.0004 0.0043 0.1682 0.2953 0.0412 4.7601 0.3365 0.4389 0.2246 0.2246  0.1060 
 [A]=3Km - loaded 0.2835 0.2253 0.0017 0.0001 0.0012 0.0168 0.1837 0.2877 1.6619 0.4714 0.3003 0.2283 0.2283   32.84 0.0364 








TABLE S3:  Resolution matrices for Fast Skeletal (Rabbit), HC WT D-S1and HC R 452C E-S1 
HF-Sk S1  ࡷ࡭ ࢑ࡼ࢏ ࢑ିࢀ ࡷࡴ ࡷ࡭ࡴ  
         ࡷ࡭ 0.008 í 0.98105 0.02946 -0.00102 -0.09029 -0.09531 ࢑ିࡼ࢏ 0.452 m0 s 0.02946 0.95335 0.00107 0.14446 0.15064 ࢑ିࢀ 1557 s-1PM-1 -0.00102 0.00107 2.5×10-6 0.00024 0.00030 ࡷࡴ 10.22 PM-1 -0.09029 0.14446 0.00024 0.84917 -0.46562 ࡷ࡭ࡴ  75.15 PM-1 -0.09531 0.15064 0.00030 -0.46562 0.81309 
                 
 
 
HC WT-D S1  ࡷ࡭ ࢑ࡼ࢏ ࢑ିࢀ ࡷࡴ ࡷ࡭ࡴ  
         ࡷ࡭ 0.011 í 0.99340 0.01164 -0.00051 -0.04754 -0.05355 ࢑ିࡼ࢏ 0.321 m0 s 0.01164 0.99653 -0.00018 0.01166 0.00802 ࢑ିࢀ 6597 s-1PM-1 -0.00051 -0.00018 2.3×10-6 0.00097 0.00103 ࡷࡴ 4.061 PM-1 -0.04754 0.01166 0.00097 0.95986 -0.02654 ࡷ࡭ࡴ  52.76 PM-1 -0.05355 0.00802 0.00103 -0.02654 0.98087 
                 
 
 
HC R452C- S1  ࡷ࡭ ࢑ࡼ࢏ ࢑ିࢀ ࡷࡴ ࡷ࡭ࡴ  
         ࡷ࡭ 0.012  í 0.96580 0.35804 -0.00010 -0.21072 -0.21505 ࢑ିࡼ࢏ 0.176 m0 s 0.35804 0.90917 0.00009 0.23395 0.23350 ࢑ିࢀ 3349 s-1PM-1 -0.00010 0.00009 0.15×10-6 0.00014 0.00015 ࡷࡴ 7.419 PM-1 -0.21072 0.23395 0.00014 0.85566 -0.13811 ࡷ࡭ࡴ  150.3 PM-1 -0.21505 0.23350 0.00015 -0.13811 0.85850 
     





TABLE S4:  Sensitivity analysis of the fitted parameters to change of +20% or -20% fixed parameters ࢑ିࡰ, ࡷࡰכ  ,  ࢑ࡰכand ࡷିࢀכ  for +&:7ȕ- S1. 
 Units Estimated 
constants 
Fixed  ࢑ିࡰ Fixed  ࡷࡰכ  Fixed  ࢑ିࡰכ  Fixed  ࡷିࢀכ Fixed  ࢑ିࢀככ 
 ࡷࡰ +20% ࡷࡰ -20% ࢑ࡰכ  +20% ࢑ࡰכ  -20% ࢑ࡰכ  +20% ࢑ࡰכ  -20% ࢑ିࢀכ  +20% ࢑ିࢀכ  -20% ࡷିࢀככ  +20% ࡷିࢀככ-20% ࡷ࡭ P0 0.01075 0.47% -2.33% 2.33% -5.12% 3.26% -6.98% 0.93% -1.40% 3.26% -0.47% ࡷࡼ࢏ m0 100 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ࡷࢀ P0 0.003 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ࡷࡴ í 8.9136 -1.48% 0.30% -2.16% 1.04% -2.55% 1.83% -0.51% 0.20% 0.97% -0.47% ࡷ࡭ࡴ í 63.145 -1.48% 0.33% -2.18% 1.06% -2.57% 1.86% -0.63% 0.20% 0.98% -0.41% 
             
Forward Rate Constants ࢑࡭ P0s 10.75 0.47% -2.33% 2.33% -5.12% 3.26% -6.98% 0.93% -1.40% 3.26% -0.47% ࢑ࡼ࢏ s 15.95 -0.31% 2.19% -2.19% 5.33% -2.82% 6.58% -0.31% 0.94% -3.45% 0.31% ࢑ࢀ P0s 10.048 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% ࢑ࡴ s 12.479 -1.48% 0.32% -2.16% 1.04% -2.55% 1.83% -0.51% 0.20% 0.97% -0.47% ࢑࡭ࡴ s 12.629 -1.49% 0.33% -2.18% 1.06% -2.57% 1.86% -0.63% 0.20% 0.98% -0.41% 
             
Backward Rate Constants ࢑ି࡭ s 1000 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ࢑ିࡼ࢏ m0s 0. 159 -0.31% 2.19% -2.19% 5.33% -2.82% 6.58% -0.31% 0.94% -3.45% 0.31% ࢑ିࢀ s 3349.37 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% ࢑ିࡴ s 1.4 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ࢑ି࡭ࡴ s 0.2 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
Numbers in bold (black) were obtained from fits to the ATPase data shown in Fig 2A & 3A.  The rest of the values were assigned as described in 





TABLE S5:  The effect of change of  ࢑ࡴ by ±20% on estimated parameters including ࢑ࡼ࢏  
 Units Estimated 
constants 
Fixed  ࢑ିࡴ   Fixed  ࢑ିࡴ 
 ࢑ࡴ +20% ࢑ࡴ -20%  ࢑ࡴ +20% ࢑ࡴ -20% ࡷ࡭ P0 0.01075 0.00758 0.0128  -29.51% 19.23% ࡷࡼ࢏ m0 100 100 100  0.00% 0.00% ࡷࢀ P0 0.003 0.003 0.003  0.00% 0.00% ࡷࡴ í 8.9136 7.1257 10.696  20.00% -20.00% ࡷ࡭ࡴ í 63.145 50.4133 75.888  -20.16% 20.18% 
        
Forward Rate Constants ࢑࡭ P0s 10.75 7.578 12.82  -29.51% 19.23% ࢑ࡼ࢏ s 15.950 23.290 13.129  46.02% -17.77% ࢑ࢀ P0s 10.048 10.042 10.047  0.00% 0.00% ࢑ࡴ s 12.479 9.976 14.975  -20.00% 20.00% ࢑࡭ࡴ s 12.629 10.083 15.178  -20.16% 20.18% 
        
Backward Rate Constants ࢑ି࡭ s 1000 1000 1000  0.00% 0.00% ࢑ିࡼ࢏ m0s 0. 159 0.233 0.131  46.48% -17.51% ࢑ିࢀ s 3349.37 3349.45 3349.17  0.00% 0.00% ࢑ିࡴ s 1.4 1.4 1.4  0.00% 0.00% ࢑ି࡭ࡴ s 0.2 0.2 0.2  0.00% 0.00% 
        
Error s 1.43x10-6 7.60x10-7 1.76x10-6    
Numbers in bold (black) were obtained from fits to the ATPase data shown in Fig 2A & 3A.  
The rest of the values were assigned as described in the methods section. Bold gray numbers  






Table S6  Change of state occupancies of intermediates in the crossbridge cycle for +&:7ȕ- S1 as a function of +/- 20% ࢑ࡴ 

























               
 
              
[A]= ࡷ࢓ 0.1865 0.0682 0.0029 0.0002 0.0020 0.0137 0.2777 0.4484 2.9750 0.7262 0.2002 0.0734 0.0734 0.2026 
[A]=3ࡷ࢓    +20%  ࢑ࡴ 0.2265 0.0681 0.0029 0.0002 0.0020 0.0119 0.2320 0.4561 2.9717 0.6881 0.2385 0.0733 0.0733 0.2026 
[A]=20ࡷ࢓   ±20%  ࢑ࡴ 0.1275 0.0681 0.0029 0.0002 0.0020 0.0164 0.3452 0.4374 2.9714 0.7826 0.1439 0.0733 0.0733 0.2025 
